FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1983530499> ?p ?o ?g. }

• W1983530499 endingPage "395" @default.
• W1983530499 startingPage "387" @default.
• W1983530499 abstract "Pediatric PulmonologyVolume 22, Issue 6 p. 387-395 State of the ArtFull Access Genotype-phenotype correlations in cystic fibrosis Eitan Kerem MD, Corresponding Author Eitan Kerem MD Department of Pediatrics, Pulmonary and Cystic Fibrosis Clinic, Shaare Zedek Medical Center Jerusalem, IsraelDepartment of Pediatrics, Pulmonary and Cystic Fibrosis Clinic. Shaare Zedek Medical Center, Jerusalem, 91031 IsraelSearch for more papers by this authorBatsheva Kerem PhD, Batsheva Kerem PhD Department of Genetics, Life Sciences Institute, Hebrew University, Jerusalem, IsraelSearch for more papers by this author Eitan Kerem MD, Corresponding Author Eitan Kerem MD Department of Pediatrics, Pulmonary and Cystic Fibrosis Clinic, Shaare Zedek Medical Center Jerusalem, IsraelDepartment of Pediatrics, Pulmonary and Cystic Fibrosis Clinic. Shaare Zedek Medical Center, Jerusalem, 91031 IsraelSearch for more papers by this authorBatsheva Kerem PhD, Batsheva Kerem PhD Department of Genetics, Life Sciences Institute, Hebrew University, Jerusalem, IsraelSearch for more papers by this author First published: December 1996 https://doi.org/10.1002/(SICI)1099-0496(199612)22:6<387::AID-PPUL7>3.0.CO;2-GCitations: 87AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Welsh MJ, Tsui L.-C. Boat TF, Beaudet AL. Cystic fibrosis. In: CL Scriver, AL Beaudet, WS Sly, D Valle, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York: McGraw-Hill, 1995: 3799–3876. 2 Highsmith WE, Lauraneli H, Burch MS, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, Quittell L, Friedman KJ, Silverman LM, Boucher RC, Knowles MR. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med. 1994; 331: 974–980. 3 Augarten A, Kerem B, Yahav Y, Noiman S, Rivlin Y, Tal Asher, Blau H, Ben-Tur L, Szeinberg A, Kerem E, Gazit E Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10kb C → Tmutation. Lancet. 1993; 342: 25–26. 4 Stewart B, Zabner J, Shuber AP, Welsh MJ, McCray PB. Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med. 1995; 151: 899–903. 5 Gaskin KJ, Gurwitz D, Durie P, Corey M, Levison H, Forstner G. Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr. 1982; 100: 857–862. 6 Corey M, Gaskin K, Durie P, Levison H, Forstner GG. Improved prognosis in CF patients with normal fat absorption. J Pediatr Gastroenterol Nutr. 1984; 3(Suppl 1): S99–S105. 7 Corey M, Durie P, Moore D, Forstner GG, Levison H. Familial concordance of pancreatic function in cystic fibrosis. J Pediatr. 1989; 115: 274–277. 8 Cystic Fibrosis Genetic Analysis Consortium. Population variations of common cystic fibrosis mutations. Hum Mutat. 1994; 4: 167–177. 9 Kerem B, Buchanan JA, Durie P, Corey M, Levison H, Buchwald M, Tsui L-C. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet. 1989; 44: 827–834. 10 Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui L-C. Identification of the cystic fibrosis gene: Genetic analysis. Science. 1989; 245: 1073–1080. 11 Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui L.-C. Collins, FS. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science. 1989; 245: 1059–1065. 12 Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelc-zak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuuzzi C, Collins FS, Tsui L-C Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science. 1989; 245: 1066–1073. 13 Kerem E, Corey M, Kerem B, Rommens JM, Markiewicz D, Levison H, Tsui LC, Durie P. The relationship between genotype and phenotype in cystic fibrosis–analysis of the most common mutation (ΔF508). N Engl J Med. 1990; 323: 1517–1522. 14 Santis G, Osborne L, Knight RA, Hodson ME. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet. 1990; 336: 1081–1084. 15 Borgo G, Mastella G, Gasparini P, Zoranello A, Doro R, Pignatti PF. Pancreatic function and genetic deletion F508 in cystic fibrosis. J Med Genet. 1990; 27: 665–669. 16 Campbell, PW III, Phillips, JA III, Krishnamani, MR, Maness, KJ, Hajinski, TA. Cystic fibrosis: Relationship between clinical status and F508 deletion. J Pediatr. 1991; 118: 239–241. 17 Johansen HK, Nir, M. Hoiby, N, Koch C, Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation. Lancet. 1991; 337: 631–634. 18 Hamosh A, King TM, Rosenstein BJ. Corey, M, Levison, H, Durie, P, Tsui, L-C, McLntosh, I, Keston, M. Brock, DJH, Macek M Jr, Zemkova D, Krasnicanova H, Vavrova V, Milan, M Sr, Golder, N, Schwarz, MJ, Super, M, Watson, EK. Williams, C, Bush, A, O'Maho-ney, SM, Humphries, P, DeArce, MA. Reis, A, Burger, J, Stuhrmann, M, Schmidtke, J, Wulbrand, U, Dork, T, Tummler, B, Cutting, GR. Cystic fibrosis patients bearing both the common missense mutation Gly → Asp at codon 551 and AF508 mutation are clinically indistinguishable from AF508 homozygotes except for decreased risk of meconium ileus. Am J Hum Genet. 1992; 51: 245–250. 19 Osborn L, Santis G, Schwartz, M. Klinger, K, Dork D, McLntosh I, Schwartz M, Nunes V, Macek, M Jr, Reiss, J, Highsmith, WE Jr, McMahon, R, Novelli, G, Malik, N. Burger J, Anvret, M, Wallace, A, Williams, C, Mathew, C Rozen, R Graham, C, Gaparini, P, Bal, J, Cassiman, JJ, Balassopoulou, A, Davidow, L, Raskin, S, Kalaydi-jieva, L, Kerem, B, Richards, S, Simon-Bouy, B, Super M, Wulbrand U, Keston M, Estivill, X. Vavrova, V, Friedman KJ, Barton D, Dallapiccola B, Stuhrmann, M. Beards, F, Hill AJM, Pignatti PF, Cuppens H, Angelicheva D, Tummler B, Brock DJH, Casals, T. Macek, M, Schmidtke J, Magee AC, Bonizzato A, DeBoeck, C. Kuffardjieva, A, Hodson M, Knight RA. Incidence and expression of the N1303K mutation of the cystic fibrosis (CFTR) gene. Hum Genet. 1992; 89: 653–658. 20 Kristidis P, Bozon D, Corey, M. Markiewicz, D, Rommens J, Tsui LC, Durie P. Genetic determinants of exocrine pancreatic function. Am J Hum Genet. 1992; 50: 1178–1184. 21 Liechti-Gallati S, Bonsall, I, Malik, N. Schneider, V, Kraemer, LG. Ruedeberg, A, Moser, H Kraemer, R. Genotype-phenotype association in cystic fibrosis: Analysis of the ΔF508, R553X and 3905insT mutations. Pediatr Res. 1992; 32: 175–178. 22 The Cystic Fibrosis Genotype-Phenotype Consortium. Correlation between genotype and phenotype in patients with cystic fibrosis. N Engl J Med. 1993; 329: 1308–1313. 23 Angelicheva D, Boteva K, Jordanova A, Savov A, Kufardjieva, A, Tolun, A, Telatar, M, Akarsubasi, A, Koprubasi, F, Aydogdu, S, Demirkol, M, Kurdoglu, G, Constantinou-Deltas, CD, Georgiou, C, Dean, H, Ivaschenko, T, Baranov, V, Kalaydjieval. Cystic fibrosis patients from the Black Sea region: The 1677delTA mutation. Hum Mutat. 1994; 3: 353–357. 24 Moullier P, Jehanne M, Audrezet MP, Mercier B, Verlingue, C. Quere, I, Guillermit, H, Raguenes, O. Stomi, V, Rault F, Ferec C. Association of 1078delT cystic fibrosis mutation with severe disease. J Med Genet. 1994: 31: 159–161. 25 Chillon M, Dork T, Casals, J. Gimenez, J, Fonknechten N, Will K, Ramos D, Nunes V, Estivill X. A novel donor splice site in intron 11 of the CFTR gene, creating a mutation 1811 + 1.6kb A → G. produces a new exon: High frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype. Am J Hum Genet. 1995; 56: 623–629. 26 Estivill X, Ortigosa L, Perez-Frias, J, Dapene, J, Ferrer, J, Pena, J, Pena, L, Llevadot, R, Gimenez, J, Nunes, V, Cobos, N, Vazquez, C, Casals, T, Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W. pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences. Hum Genet. 1995; 95: 331–336. 27 Stern RC, Doershuk C, Drumm ML. 3849 + 10 kbC → T mutation and disease severity in cystic fibrosis. Lancet. 1995; 346: 274–276. 28 Gan KH, Veeze JH. van den Ouweland, AMW, Halley, DJJ, Scheffer, H, van der Hout, A, Overbeek, SE, de Jongste, JC, Bakker, W, Heijerman, GM, A cystic fibrosis mutation associated with mild lung disease. N Engl J Med. 1995; 333: 95–99. 29 Varon R, Sturmann, M, Macek, M, Kufardjieva, A, Angelicheva, D, Magdorf, K, Jordanova, A, Savov, A, Wahn, U, Macek, M, Lalov, V, Lanova, T, Ellemunter, H, Vavrova, V, Ferak V, Kayserova H, Reis A, Kalaydjieva L. Pancreatic insufficiency and pulmonary disease in German and Slavic cystic fibrosis patients with the R347P mutation. Hum Mutat. 1995; 6: 219–225. 30 Kerem E, Nissim M, Argaman Z, Yahav Y, Augarten A, Chiba O, Moran I, Kerem B. Extremely high variability of clinical presentation among patients carrying the missense mutation G85E. Pediatr Pulmonol. 1994; s10: 212 31 Chu CS, Trapnell BC, Curristin SM, Cutting GR, Crystal RG. Extensive posttranscriptional deletion of the coding sequences of part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J Clin Invest. 1992; 90: 785–790. 32 Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nature Genet. 1993; 3: 151–156. 33 Osborne LR, Alton EWFW, Tsui LC. CFTR intron 9 poly-T tract length in men with congenital absence of the vas deferens. Pediatr Pulmonol. 1994; s10: 214 34 Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey M-C, Ruiz-Romero J, Verlingue C, Claustres M, Nunes V, Ferec C, Estivill X Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med. 1995; 332: 1475–1480. 35 Jarvi K, Zielenski J, Wilschanski M, Durie P, Buckspan M, Tullis E, Markievicz D, Tsui LC. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet. 1995; 345: 1578 36 Kerem E, Harel-Rave N, Augarten A, Goshen R, Nissim-Rafinia M, Madjar I, Yahav Y, Bentur L, Rivlin J, Kerem B. Clinical presentation of patients carrying the 5T thymidine tract in intron 8–from healthy individuals to typical CF. Pediatr Pulmonol. 1995; s12: 203 37 Knowles MR, Gatzy J, Boucher R. Increased bioelectrical potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 1981; 305: 1489–1495. 38 Knowles MR, Paradiso AM, Boucher R. In vivo nasal potential difference: Techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther. 1995; 6: 445–455. 39 Osborne LR, Lynch M, Middleton PG, Alton EWFW, Geddes DM, Pryor JR, Hodson ME, Santis GK. Nasal epithelial ion transport and genetic analysis of infertile men with congenital absence of the vas deferens. Hum Mol Genet. 1993; 2: 1605–1609. 40 Veeze HJ, Halley DJJ, Bijman J, de Jongst, JC, de Jongste, HR, Sinaasappel, M. Determinants of mild clinical symptoms in cystic fibrosis. Residual chloride secretion in rectal biopsies in relation to the genotype. J Clin Invest. 1994; 93: 461–466. 41 Stern RC, Boat TF, Abramowsky CR, Matthews LW, Wood RE, Doershuk CF. Intermediate-range sweat chloride concentration and pseudomonas bronchitis. A cystic fibrosis variant with preservation of exocrine pancreatic function. JAMA. 1978; 239: 2676–2680. 42 Davis PB, Hubbard VS, Di Sant' Agnese, PA. Low sweat electrolytes in a patient with cystic fibrosis. Am J Med. 1980; 69: 643–646. 43 Romano L, Minicucci L, Schiaffino MC, Serravalle P, Diana MC, Romano C. Uncommon presenting manifestations of cystic fibrosis: A clinical alert. Padiatr Padol. 1995; 30: 1–7. 44 Leoni G, Pitzalis S, Podda R, Zanda M, Silvetti M, Caocci L, Cao A, Rosatelli MC. A specific cystic fibrosis mutation (T338I) associated with the phenotype of isolated hypotonic dehydration. J Pediatr. 1995; 127: 281–283. 45 Holsclaw DS, Lobel B, Jockin H, Shwachman H. Genital abnormalities in male patients with cystic fibrosis. J Urol. 1971; 106: 568–574. 46 Anguiano A, Oates RD, Amos JA, Dean M, Gerrard B, Stewart C, Maher TA, White MB, Milunsky A. Congenital bilateral absence of the vas deferens, a primary genital form of cystic fibrosis. JAMA. 1992; 267: 1794–1797. 47 Osborne LR, Lynch M, Middleton PG, Alton EWFW, Geddes DM, Pryor JR, Hodson ME, Santis GK. Nasal epithelial ion transport and genetic analysis of infertile men with congenital absence of the vas deferens. Hum Mol Genet. 1993; 2: 1605–1609. 48 Culard JF, Desgeorges M, Costa P, Laussel M, Razkatzara G, Navratil H, Demaille J, Claustres M. Analysis of the whole CFTR coding regions and splice junctions in azospermic men with congenital bilateral absence of epididymis or vas deferens. Hum Genet. 1994; 93: 467–470. 49 Oates RD, Amos JA. The genetic basis of congenital absence of the vas deferens and cystic fibrosis. J. Androl. 1994; 15: 1–8. 50 Mercier B, Verlingue C, Lissens W, Silber SJ, Novelli G, Bonduelle M, Audrezet MP, Ferec C. Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am J Hum Genet. 1995; 56: 272–277. 51 Casals T, Bassas L, Ruiz-Romero J, Chillon M, Gimenez J, Ramos MD, Tapia G, Narvaez H, Nunes V, Estivill X. Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: In 50% of cases only one CFTR allele could be detected. Hum Genet. 1995; 95: 205–211. 52 Rave-Harel N, Madgar I, Goshen R, Nissim-Rafina M, Ziadni A, Rahat A, Chiba O, Kalman YM, Brautbar C, Levison D, Augarten A, Kerem E, Kerem B. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am J Hum Genet. 1995; 56: 1359–1366. 53 Tsui L-C. The spectrum of cystic fibrosis mutations. TIG. 1992; 8: 392–398. 54 Sheppard DN, Carson MR, Ostedgaard LS, Denning GM, Welsh MJ. Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium. Am J Physiol. 1994; 266: L405–L413. 55 Yang Y, Engelhardt JF, Wilson JM. Ultrastructural localization of variant forms of cystic fibrosis transmembrane conductance regulator in human bronchial epithelia of xenografts. Am J Respir Cell Mol Biol. 1994; 11: 7–15. 56 Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993; 73: 1251–1254. 57 Wilshanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr. 1995; 127: 705–710. 58 Kerem E, Kerem B. The relationship between genotype and phenotype in cystic fibrosis. Curr Opin Pulmonary Med. 1995; 1: 450–456. 59 Egan M, Flotte T, Afione S, Solow R, Zeitlin PL, Carter BJ, Guggino WB. Defective regulation of outwardly rectifying Cl- channels by protein kinase A corrected by insertion of CFTR. Nature. 1992; 358: 581–584. 60 Boucher RC, Stutts MJ, Knowles MR, Cantly L, Gatzy JT. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest. 1986; 78: 1245–1252. 61 Stutts JM, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, Boucher RC. CFTR as a cAMP-dependent regulator of sodium channels. Science. 1995; 269: 847–850. 62 Dörk T, Wulbrand U, Richter T, Neumann T, Wolfes H, Wulf B, Maass E, Tümmler B. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene. Hum Genet. 1991; 87: 441–446. 63 Kiesewetter S, Macek, M Jr, Davis, C, Currustin, SM, Chu, C-S, Graham, C, Shrimpton, AE, Cashman, SM, Tsui, L-C, Mickle, J, Amos, J, Highsmith, WE, Shuber, A, Witt, DR, Crystal, RG, Cutting, GR. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nature Genet. 1993; 5: 274–278. 64 Shoshani T, Kerem E, Ben-Tur L, Tal A, Szeinberg A, Yahav Y, Augarten A, Kerem B. Association between pulmonary function and levels of aberrantly spliced mRNA transcribed in epithelial cells from the 3849 + 10kb C → T alle 1. Pediatr Pulmonol. 1994; s10: 213 65 Kerem B, Rave-Harel N, Nissim-Rafina M, Goshen R, Madgar I, Augarten A, Kerem E. Variable levels of aberrantly spliced CFTR mRNA transcribed from the 5T allele: The cause for variable disease severity among individuals and between organs of the same individual. Am J Hum Genet. 1995; s57: 1412 66 Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of the mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature. 1992; 358: 761–764. 67 Pignatti PF, Bombieri C, Marigo C, Benetazzo M, Luisetti M. Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum Mol Genet. 1995; 4: 635–639. 68 Dumur V, Lafitte JJ, Gervais R, Debaecker D, Kesteloot M, Lalau G, Roussel P. Abnormal distribution of cystic fibrosis ΔDLF508 allele in adults with chronic bronchial hypersecretion. Lancet. 1990; 335: 1340 69 Gervais R, Lafitte JJ, Dumur V, Kestelott M, Lalau G, Houdret N, Roussel P. Sweat chloride and ΔDLF508 mutation in chronic bronchitis or bronchiectasis. Lancet 1993; 342: 997 70 Simon-Bouy B, Stern M, Taillandier A, Mornet E, Boue A, Caubarrere I. Increased frequency of the ΔDLF508 mutation in patients with bronchiectasis. Pediatr Pulmonol. 1993; s9: 237 71 Miller PW, Macek M, Hamosh A, Walden S, Loury MC, Cutting GR. Identification of CFTR mutations in adult patients with allergic bronchopulmonary aspergillosis and chronic pseudomonas bronchitis. Pediatr Pulmonol. 1993; s9: 237 72 Wiatrik BJ, Myer CM, Cotton RT. Cystic fibrosis presenting with sinus disease in children. Am J Dis Child. 1993; 147: 258 73 Burger J, Macek MJ, Stuhrman M, Reis A, Krawczak M, Schmidtke J. Genetic influences in the formation of nasal polyps. Lancet. 1991; 337: 974 74 Laroche D, Travert G. Abnormal frequency of ΔDLF508 mutation in neonatal transitory hypertrypsinemia. Lancet. 1991; 337: 55 75 Kerem B, Harel-Rave N, Nissim-Rafina M, Goshen R, Madjar I, Augarten A, Kerem E. Variable levels of aberrantly spliced CFTR mRNA transcribed from the 5T allele: The cause for variable disease severity among individuals and between organs of the same individuals. Am J Hum Genet. 1995; s57: 1412 76 Cystic fibrosis genotype-phenotype consortium. Variable phenotypes for nine CFTR mutations associated with pancreatic sufficiency in CF patients. Pediatr Pulmonol. 1996; s13: 245 Citing Literature Volume22, Issue6December 1996Pages 387-395 ReferencesRelatedInformation" @default.
• W1983530499 created "2016-06-24" @default.
• W1983530499 creator A5016355952 @default.
• W1983530499 creator A5052847233 @default.
• W1983530499 date "1996-12-01" @default.
• W1983530499 modified "2023-10-17" @default.
• W1983530499 title "Genotype-phenotype correlations in cystic fibrosis" @default.
• W1983530499 cites W1547921699 @default.
• W1983530499 cites W185124257 @default.
• W1983530499 cites W1968561725 @default.
• W1983530499 cites W1969697265 @default.
• W1983530499 cites W1973058630 @default.
• W1983530499 cites W1978151850 @default.
• W1983530499 cites W1983319519 @default.
• W1983530499 cites W1992831558 @default.
• W1983530499 cites W1994434210 @default.
• W1983530499 cites W2000151968 @default.
• W1983530499 cites W2001046277 @default.
• W1983530499 cites W2011777684 @default.
• W1983530499 cites W2019099644 @default.
• W1983530499 cites W2020458135 @default.
• W1983530499 cites W2021002510 @default.
• W1983530499 cites W2021739826 @default.
• W1983530499 cites W2023243075 @default.
• W1983530499 cites W2028859322 @default.
• W1983530499 cites W2028867864 @default.
• W1983530499 cites W2033909465 @default.
• W1983530499 cites W2033926035 @default.
• W1983530499 cites W2035504075 @default.
• W1983530499 cites W2039529907 @default.
• W1983530499 cites W2039599894 @default.
• W1983530499 cites W2043502964 @default.
• W1983530499 cites W2046049792 @default.
• W1983530499 cites W2048056908 @default.
• W1983530499 cites W2051019242 @default.
• W1983530499 cites W2052588826 @default.
• W1983530499 cites W2065541938 @default.
• W1983530499 cites W2071935958 @default.
• W1983530499 cites W2076934605 @default.
• W1983530499 cites W2079234445 @default.
• W1983530499 cites W2079750805 @default.
• W1983530499 cites W2080130466 @default.
• W1983530499 cites W2103705836 @default.
• W1983530499 cites W2116830768 @default.
• W1983530499 cites W2125391335 @default.
• W1983530499 cites W2126101868 @default.
• W1983530499 cites W2126458759 @default.
• W1983530499 cites W2126609769 @default.
• W1983530499 cites W2139574634 @default.
• W1983530499 cites W2146425189 @default.
• W1983530499 cites W2148695834 @default.
• W1983530499 cites W2151589932 @default.
• W1983530499 cites W2155495967 @default.
• W1983530499 cites W2169674844 @default.
• W1983530499 cites W2320394900 @default.
• W1983530499 cites W2321558259 @default.
• W1983530499 cites W2327703579 @default.
• W1983530499 cites W2336764462 @default.
• W1983530499 cites W2337925307 @default.
• W1983530499 cites W2399234860 @default.
• W1983530499 cites W4232531177 @default.
• W1983530499 cites W4249191093 @default.
• W1983530499 cites W4319308443 @default.
• W1983530499 doi "https://doi.org/10.1002/(sici)1099-0496(199612)22:6<387::aid-ppul7>3.0.co;2-g" @default.
• W1983530499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9016472" @default.
• W1983530499 hasPublicationYear "1996" @default.
• W1983530499 type Work @default.
• W1983530499 sameAs 1983530499 @default.
• W1983530499 citedByCount "118" @default.
• W1983530499 countsByYear W19835304992012 @default.
• W1983530499 countsByYear W19835304992013 @default.
• W1983530499 countsByYear W19835304992014 @default.
• W1983530499 countsByYear W19835304992015 @default.
• W1983530499 countsByYear W19835304992016 @default.
• W1983530499 countsByYear W19835304992017 @default.
• W1983530499 countsByYear W19835304992018 @default.
• W1983530499 countsByYear W19835304992019 @default.
• W1983530499 countsByYear W19835304992020 @default.
• W1983530499 countsByYear W19835304992021 @default.
• W1983530499 countsByYear W19835304992022 @default.
• W1983530499 countsByYear W19835304992023 @default.
• W1983530499 crossrefType "journal-article" @default.
• W1983530499 hasAuthorship W1983530499A5016355952 @default.
• W1983530499 hasAuthorship W1983530499A5052847233 @default.
• W1983530499 hasBestOaLocation W19835304991 @default.
• W1983530499 hasConcept C104317684 @default.
• W1983530499 hasConcept C126322002 @default.
• W1983530499 hasConcept C127716648 @default.
• W1983530499 hasConcept C135763542 @default.
• W1983530499 hasConcept C142724271 @default.
• W1983530499 hasConcept C2776938444 @default.
• W1983530499 hasConcept C54355233 @default.
• W1983530499 hasConcept C71924100 @default.
• W1983530499 hasConcept C86803240 @default.
• W1983530499 hasConceptScore W1983530499C104317684 @default.
• W1983530499 hasConceptScore W1983530499C126322002 @default.
• W1983530499 hasConceptScore W1983530499C127716648 @default.
• W1983530499 hasConceptScore W1983530499C135763542 @default.

• next